
Get Ready to See Opthea Shine at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight in 2024!
Welcome to the Exciting World of Retinal Disease Therapies! Opthea Limited: Revolutionizing the Treatment of Wet AMD Opthea Limited, a cutting-edge biopharmaceutical company based in Melbourne, Australia and Princeton, New Jersey, is making waves in the medical community with its groundbreaking advancements in treating retinal diseases. In a recent announcement, Opthea revealed its innovative therapy,…